Ce Tang

1.4k total citations · 1 hit paper
45 papers, 996 citations indexed

About

Ce Tang is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Ce Tang has authored 45 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 21 papers in Pharmacology and 17 papers in Complementary and alternative medicine. Recurrent topics in Ce Tang's work include Traditional Chinese Medicine Analysis (15 papers), Plant-based Medicinal Research (11 papers) and Pharmacological Effects of Natural Compounds (11 papers). Ce Tang is often cited by papers focused on Traditional Chinese Medicine Analysis (15 papers), Plant-based Medicinal Research (11 papers) and Pharmacological Effects of Natural Compounds (11 papers). Ce Tang collaborates with scholars based in China, Nigeria and Pakistan. Ce Tang's co-authors include Xianli Meng, Yi Zhang, Jinrong Bai, Ya Hou, Yunsen Zhang, Xiaobo Wang, Xiaopeng Ai, Xiaorui Chen, Gang Fan and Yi Zhang and has published in prestigious journals such as Food Chemistry, Trends in Food Science & Technology and Molecules.

In The Last Decade

Ce Tang

42 papers receiving 985 citations

Hit Papers

Gallic acid: Pharmacological activities and molecular mec... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ce Tang China 14 417 200 187 160 140 45 996
Xiaojian Gong China 18 433 1.0× 143 0.7× 208 1.1× 129 0.8× 122 0.9× 59 966
Mingqiu Shan China 18 522 1.3× 153 0.8× 261 1.4× 242 1.5× 120 0.9× 47 1.1k
Jung Chao Taiwan 15 379 0.9× 181 0.9× 173 0.9× 162 1.0× 134 1.0× 28 855
Jiagang Deng China 22 475 1.1× 225 1.1× 253 1.4× 331 2.1× 118 0.8× 110 1.4k
Siyu Zhao China 15 484 1.2× 128 0.6× 234 1.3× 129 0.8× 110 0.8× 52 1.1k
Wenzhe Huang China 20 518 1.2× 245 1.2× 245 1.3× 243 1.5× 116 0.8× 102 1.2k
Guoyue Zhong China 18 549 1.3× 182 0.9× 297 1.6× 191 1.2× 104 0.7× 126 944
Yanyun Che China 15 471 1.1× 120 0.6× 257 1.4× 204 1.3× 77 0.6× 33 830
Qinwan Huang China 19 611 1.5× 298 1.5× 231 1.2× 191 1.2× 298 2.1× 68 1.4k

Countries citing papers authored by Ce Tang

Since Specialization
Citations

This map shows the geographic impact of Ce Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ce Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ce Tang more than expected).

Fields of papers citing papers by Ce Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ce Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ce Tang. The network helps show where Ce Tang may publish in the future.

Co-authorship network of co-authors of Ce Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Ce Tang. A scholar is included among the top collaborators of Ce Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ce Tang. Ce Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yuanyuan, Xinyi Cheng, Qing Yu, et al.. (2025). Versatile platforms based on HPTLC: Multimodal and green solutions for food and herbal quality assurance. Trends in Food Science & Technology. 165. 105310–105310.
2.
Yu, Qing, Mingyuan Meng, Xing Yang, et al.. (2025). Exosomes in Disease Therapy: Plant-Derived Exosome-Like Nanoparticles Current Status, Challenges, and Future Prospects. International Journal of Nanomedicine. Volume 20. 10613–10644. 4 indexed citations
3.
He, Yuqi, Xinyan Zhao, Dixiong Yang, et al.. (2025). Affinity Ultrafiltration Mass Spectrometry for Screening Active Ingredients in Traditional Chinese Medicine: A Review of the Past Decade (2014–2024). Molecules. 30(3). 608–608. 2 indexed citations
4.
Wang, Fangjie, Ce Tang, Ruixia Wu, et al.. (2024). LC-MS based metabonomics study on protective mechanism of ESWW in cerebral ischemia via CYTC/Apaf-1/NDRG4 pathway. Phytomedicine. 128. 155543–155543. 3 indexed citations
7.
Liu, Yue, Mengjia Li, Xing Fu, Yi Zhang, & Ce Tang. (2023). An integrated strategy of UPLC-Q-TOF/MS and HPTLC/PAD-DESI-MSI for the analysis of chemical variations: A case study of Tibetan medicine Tiebangchui. Journal of Pharmaceutical Analysis. 14(4). 100907–100907. 6 indexed citations
8.
Li, Wenjie, et al.. (2023). Astragaloside IV, as a potential anticancer agent. Frontiers in Pharmacology. 14. 34 indexed citations
10.
Yang, Hailing, Qiuyue Li, Ning Li, et al.. (2022). Protective Effect of Brassica rapa Polysaccharide against Acute High‐Altitude Hypoxia‐Induced Brain Injury and Its Metabolomics. Oxidative Medicine and Cellular Longevity. 2022(1). 3063899–3063899. 5 indexed citations
11.
Li, Congying, Zhen Zhou, Tong Xu, et al.. (2022). Aconitum pendulum and Aconitum flavum: A narrative review on traditional uses, phytochemistry, bioactivities and processing methods. Journal of Ethnopharmacology. 292. 115216–115216. 25 indexed citations
12.
Liang, Yan, Min Xu, Ce Tang, et al.. (2022). The study of chemical components in Qishiwei Zhenzhu pills and its anti-apoptotic mechanism in cerebral ischemic based on LC-MS and network pharmacology. Journal of Ethnopharmacology. 302(Pt A). 115891–115891. 8 indexed citations
13.
Wang, Wenxiang, et al.. (2021). Chlorogenic acid, a natural product as potential inhibitor of COVID-19: virtual screening experiment based on network pharmacology and molecular docking. Natural Product Research. 36(10). 2580–2584. 38 indexed citations
14.
Chen, Ke, Ning Li, Fangfang Fan, et al.. (2021). Tibetan Medicine Duoxuekang Capsule Ameliorates High-Altitude Polycythemia Accompanied by Brain Injury. Frontiers in Pharmacology. 12. 680636–680636. 18 indexed citations
15.
Tang, Ce, Chengcheng Zhao, Huan Yi, et al.. (2020). Traditional Tibetan Medicine in Cancer Therapy by Targeting Apoptosis Pathways. Frontiers in Pharmacology. 11. 976–976. 36 indexed citations
16.
Wang, Wenxiang, et al.. (2020). Virtual Screening Technique Used to Estimate the Mechanism of Adhatoda vasica Nees for the Treatment of Rheumatoid Arthritis Based on Network Pharmacology and Molecular Docking. Evidence-based Complementary and Alternative Medicine. 2020(1). 5872980–5872980. 12 indexed citations
17.
Bai, Jinrong, Yunsen Zhang, Ce Tang, et al.. (2020). Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases. Biomedicine & Pharmacotherapy. 133. 110985–110985. 480 indexed citations breakdown →
19.
Wang, Chen, Lianming Du, Wujiao Li, et al.. (2016). Comparison of microsatellite distribution in genomes of Centruroides exilicauda and Mesobuthus martensii. Gene. 594(1). 41–46. 6 indexed citations
20.
He, Yang, Pei Hou, Gang Fan, et al.. (2012). Authentication ofAngelica anomalaAvé-Lall cultivars through DNA barcodes. Mitochondrial DNA. 23(2). 100–105. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026